Metraipolis › archive › dc_a7b0faac4a42

An Overview of Cefiderocol's Therapeutic Potential and Underlying Resistance Mechanisms — Europe PMC PMID:37511802

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37511802
DOI
10.3390/life13071427
License (as archived)
solo-consultazione
Archived
2026-10-08T14:40:43.713Z
SHA-256 of the archived text
190de5298763a786b4ea49d2d32ed5a3a4f6fe3a64fb95085a30f416ccc1ff8a
Stable URL of this page
https://metraipolis.com/documento/dc_a7b0faac4a42

How to cite

An Overview of Cefiderocol's Therapeutic Potential and Underlying Resistance Mechanisms — Europe PMC PMID:37511802 — Europe PMC (en), https://europepmc.org/article/MED/37511802 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a7b0faac4a42 (Metraipolis archive dc_a7b0faac4a42, sha256 190de5298763a786b4ea49d2d32ed5a3a4f6fe3a64fb95085a30f416ccc1ff8a)
BibTeX
@misc{dca7b0faac4a42,
  title = {An Overview of Cefiderocol's Therapeutic Potential and Underlying Resistance Mechanisms — Europe PMC PMID:37511802},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37511802},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a7b0faac4a42; sha256 190de5298763a786b4ea49d2d32ed5a3a4f6fe3a64fb95085a30f416ccc1ff8a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/37511802. Agents can read the archived copy with the MCP tool read_document.